According to a recent comprehensive by MarkNtel Advisors Radiopharmaceuticals Market research report, the Radiopharmaceuticals market is set for significant growth, driven by factors such as market size, share, and evolving trends.
This detailed report offers crucial insights into the market, covering key aspects such as market segmentation and definitions. It outlines the main drivers of growth and provides a clear forecast of the industry’s future direction. Additionally, the study provides a thorough overview of the competitive landscape, detailing recent developments and regional distribution across major areas. An expert competitor analysis delivers an in-depth understanding of market dynamics, offering strategic recommendations for businesses and investors.
With its robust analysis and forward-looking projections, this report is an essential resource for stakeholders aiming to leverage emerging opportunities and address potential challenges in the Radiopharmaceuticals market.
Get a Sample PDF of Report - https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html
Radiopharmaceuticals Market (2025-2030): Analysis and Growth
The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2025 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30.
What are the key drivers fueling growth in the Radiopharmaceuticals market from 2025-2030?
Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2025 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.
Radiopharmaceuticals Market : Segmentation Analysis
-By Radioisotope
-Technetium 99- Market Size & Forecast 2019-2030, USD Million
-Fluorine 18- Market Size & Forecast 2019-2030, USD Million
-Iodine 131- Market Size & Forecast 2019-2030, USD Million
-Gallium 68- Market Size & Forecast 2019-2030, USD Million
-Iodine 123- Market Size & Forecast 2019-2030, USD Million
-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million
-By Indication
-Oncology- Market Size & Forecast 2019-2030, USD Million
-Cardiology- Market Size & Forecast 2019-2030, USD Million
-Gastroenterology- Market Size & Forecast 2019-2030, USD Million
-Nephrology- Market Size & Forecast 2019-2030, USD Million
-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million
-By Type
-Diagnostic- Market Size & Forecast 2019-2030, USD Million
-Therapeutic- Market Size & Forecast 2019-2030, USD Million
-By End User
-Hospitals- Market Size & Forecast 2019-2030, USD Million
-Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million
-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million
-By Region
-North America
-South America
-Europe
-The Middle East & Africa
-Asia-Pacific
Explore the Complete Analysis Report – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html
What role do key competitors play in shaping the market, and how are they adapting to emerging trends and challenges?
Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.
“Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.”
Key Report Highlights
· Market Dimensions & Projections
· Pricing Evaluation,
· Recent Strategic Moves by Companies,
· Primary Stakeholders,
· Analysis of Import and Export Trends,
· Competitive Landscape Assessment,
· Emerging Opportunities,
· Market Trends and Indicators
More Reports:
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek